Rectal flunitrazepam as premedication in preschool children. A double-blind randomized study

C Estève1, I Murat, C Saint-Maurice

  • 1Department of Paediatric Anaesthesia, Hopital Saint Vincent de Paul, Paris, France.

Insights

Rectal flunitrazepam (0.04 mg.kg-1) effectively sedated young children before anesthesia. This low-dose premedication improved mask acceptance and induction, with no adverse events observed, making it a safe option.

Area of Science:

  • Pediatric Anesthesiology
  • Pharmacology
  • Preoperative Medicine

Background:

  • Premedication in pediatric anesthesia aims to reduce anxiety and facilitate induction.
  • Rectal administration offers a non-invasive route for young children.
  • Flunitrazepam is a benzodiazepine with sedative properties.

Purpose of the Study:

  • To evaluate the efficacy and safety of low-dose rectal flunitrazepam as a premedicant in children under 5 years.
  • To compare flunitrazepam premedication with placebo for inhalational induction.

Main Methods:

  • Double-blind, placebo-controlled study involving 40 children under 5 years.
  • Rectal flunitrazepam (0.04 mg.kg-1) administered 15 minutes before halothane mask induction.
  • Assessment of sedation, mask acceptance, and induction scores.

Main Results:

  • Significantly better sedation, mask acceptance, and induction scores in the flunitrazepam group.
  • No hypoxic episodes or prolonged sedation were reported in either group.
  • Rectal flunitrazepam demonstrated a favorable safety profile.

Conclusions:

  • Low-dose rectal flunitrazepam is an effective and acceptable premedicant for young children.
  • It improves the process of inhalational anesthesia induction.
  • This method offers a safe and well-tolerated alternative for pediatric premedication.